Obstructive sleep apnea (OSA) affects a significant portion of the adult population, with about 34% of middle-aged men and 17% of women meeting diagnostic criteria. Its prevalence is even higher among people with cardiovascular conditions such as hypertension, heart failure, and coronary artery disease, reaching up to 80% in some groups1. Sleep apnea disrupts breathing during sleep, leading to drops in blood oxygen levels and triggering stress responses that can worsen heart health2. Understanding the link between sleep apnea severity and cardiovascular disease risk is crucial for improving patient outcomes.
“Our findings suggest that CPAP may offer long-term cardiovascular benefit in people with high-risk OSA but may have unintended harmful effects in those without high-risk OSA.”
— Ali Azarbarzin, Brigham and Women's Hospital and Harvard Medical School14
Sleep Apnea Severity and Cardiovascular Disease Risk
Obstructive sleep apnea is characterized by repeated episodes of partial or complete blockage of the upper airway during sleep, causing intermittent drops in blood oxygen (hypoxemia), sleep fragmentation, and surges in sympathetic nervous system activity1. These physiological disturbances contribute to elevated blood pressure, increased heart rate, systemic inflammation, endothelial dysfunction, and insulin resistance—all key factors in the development of cardiovascular disease (CVD)345.
The severity of sleep apnea, measured by the apnea-hypopnea index (AHI), strongly influences cardiovascular risk. For every 10-unit increase in AHI, the adjusted hazard ratio for coronary heart disease rises by 1.10, and for heart failure by 1.136. Severe OSA (AHI ≥30) is associated with a 68% higher risk of coronary heart disease and a 58% higher risk of heart failure compared to mild OSA (AHI <5)6. Moderate to severe OSA is more strongly linked to incident cardiovascular disease than mild cases67. Even mild OSA independently increases the risk of hypertension38.
Sleep apnea events during rapid eye movement (REM) sleep tend to be longer and cause deeper oxygen desaturations, which may have a greater cardiovascular impact than events in other sleep stages9. The repeated oxygen fluctuations and sympathetic surges can damage blood vessels and promote atherosclerosis, increasing the risk of heart attacks and strokes2.
“We know that OSA is linked to cardiovascular disease but clinical studies of treating OSA with CPAP have not shown a long-term cardiovascular benefit. This creates uncertainty about whether all people with OSA should be treated.”
— Ali Azarbarzin, Brigham and Women's Hospital and Harvard Medical School14
Treatment with continuous positive airway pressure (CPAP) therapy, which keeps the airway open by delivering pressurized air during sleep, can reduce cardiovascular risk, especially in patients experiencing significant oxygen desaturation and heart rate increases101112. CPAP stabilizes breathing, improves sleep quality, and minimizes oxygen drops related to sleep apnea101311. Weight loss and positional therapy also help reduce OSA severity and its cardiovascular consequences101311.
| Severity of OSA (AHI) | Cardiovascular Risk Increase | Source |
|---|---|---|
| Mild (<5) | Baseline risk | 6 |
| Moderate (15–29) | Elevated risk, stronger association | 67 |
| Severe (≥30) | 68% higher coronary heart disease risk; 58% higher heart failure risk | 6 |
Obstructive sleep apnea is linked to a 140% increased risk of heart failure, a 60% increased risk of stroke, and a 30% increased risk of coronary heart disease1415. The condition is also associated with a higher likelihood of heart arrhythmias, with patients being 2-4 times more likely to develop irregular heartbeats than those without OSA16. These risks highlight the importance of early diagnosis and treatment.
Other Sleep Disorders and Heart Disease Risk
Sleep disorders beyond obstructive sleep apnea also contribute to cardiovascular risk. Conditions such as insomnia, short sleep duration, and periodic limb movements during sleep have all been linked to increased rates of hypertension and heart disease1087. Chronic insomnia, in particular, is associated with higher blood pressure and greater heart disease risk1087.
Continuous positive airway pressure (CPAP) lowers the risk of serious cardiovascular events in some patients with obstructive sleep apnea (OSA) but not others. In patients with high-risk OSA, CPAP lowered the risk of heart attack, stroke and death from cardiovascular disease by around 17%.
Central sleep apnea (CSA), characterized by unstable ventilatory control during sleep, often occurs in patients with cardiovascular comorbidities such as heart failure18. CSA exacerbates cardiovascular strain and reduces quality of life, especially in those with acute decompensated heart failure19. Hypoventilation syndromes also fall under sleep-disordered breathing and can negatively impact heart health1087.
Sleep disorders affect the quality, timing, and amount of sleep, all of which are essential for heart and depression diagnosis process and criteria health20. Poor sleep can worsen obesity, high blood pressure, and diabetes—major risk factors for cardiovascular disease20. Additionally, sleep deprivation and disorders increase systemic inflammation, further elevating cardiovascular risk20.
- Insomnia is linked to increased hypertension and heart disease risk1087.
- Short sleep duration raises the likelihood of cardiovascular disease1087.
- Periodic limb movements during sleep contribute to cardiovascular risk1087.
- Central sleep apnea is common in patients with heart failure and worsens cardiovascular outcomes1918.
- Sleep disorders promote inflammation and metabolic changes that harm heart health20.
I refer patients with atrial fibrillation and other arrhythmias for sleep evaluations at the UChicago Medicine Sleep Center. Sleep disorders, especially untreated sleep apnea, can activate cardiac arrhythmias and elevate blood pressure, as well as lead to weight gain.
How to Lower Your Cardiovascular Disease Risk
Early diagnosis and treatment of sleep apnea and other sleep disorders are key to reducing cardiovascular risk. Continuous positive airway pressure (CPAP) remains the gold standard for treating obstructive sleep apnea1311. CPAP devices deliver pressurized air to keep the airway open during sleep, preventing oxygen desaturations and stabilizing breathing1311. This therapy improves sleep quality and can lower the risk of heart attacks, strokes, and heart failure in patients with significant oxygen drops and heart rate surges101112.
Heart doctors should pay more attention to obstructive sleep apnea (OSA), which can worsen heart disease but often is unrecognized and undertreated. OSA is characterized by snoring and disrupted sleep, and can worsen heart conditions.17
💡 Did You Know?
Heart doctors should pay more attention to obstructive sleep apnea (OSA), which can worsen heart disease but often is unrecognized and undertreated. OSA is characterized by snoring and disrupted sleep, and can worsen heart conditions17.
Weight reduction and positional therapy are effective adjuncts to CPAP, helping to decrease the severity of sleep apnea and its cardiovascular consequences101311. Positional therapy involves avoiding sleeping on the back, which can worsen airway obstruction10.
Key strategies to reduce cardiovascular risk related to sleep disorders include:
- Early screening for sleep apnea in patients with resistant hypertension, pulmonary hypertension, or recurrent atrial fibrillation1.
- Using CPAP therapy to maintain airway patency and reduce oxygen desaturation1311.
- Encouraging weight loss to lower the risk and severity of OSA101311.
- Employing positional therapy to minimize airway obstruction during sleep101311.
- Managing other sleep disorders such as insomnia and central sleep apnea with appropriate interventions191810.
